IL-10 Antikörper
Kurzübersicht für IL-10 Antikörper (ABIN2665090)
Target
Alle IL-10 (IL10) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
- 
    
- 
                                            
Kreuzreaktivität
 - Pavian, Rhesusaffen, Cynomolgus
 - 
                                            
Aufreinigung
 - The antibody was purified by affinity chromatography.
 - 
                                            
Isotyp
 - IgG1 kappa
 
 - 
                                            
 - 
    
 - 
    
- 
                                            
Applikationshinweise
 - Optimal working dilution should be determined by the investigator.
 - 
                                            
Beschränkungen
 - Nur für Forschungszwecke einsetzbar
 
 - 
                                            
 - 
    
- 
                                            
Konzentration
 - 0.5 mg/mL
 - 
                                            
Buffer
 - Phosphate-buffered solution, pH 7.2, containing 0.09 % sodium azide.
 - 
                                            
Konservierungsmittel
 - Sodium azide
 - 
                                            
Vorsichtsmaßnahmen
 - This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
 - 
                                            
Lagerung
 - 4 °C
 - 
                                            
Informationen zur Lagerung
 - The antibody solution should be stored undiluted between 2°C and 8°C.
 
 - 
                                            
 - 
    
- IL-10 (IL10) (Interleukin 10 (IL10))
 - 
                                            
Andere Bezeichnung
 - IL-10
 - 
                                            
Hintergrund
 - IL-10 was originally described as Cytokine Synthesis Inhibitory Factor (CSIF) by virtue of its ability to inhibit cytokine production by Th1 clones. IL-10 shares over 80 % sequence homology with the Epstein-Barr virus protein BCRFI. The biological activities of IL-10 include inhibition of macrophage-mediated cytokine synthesis, suppression of the delayed type hypersensitivity response, and stimulation of the Th2 cell response, which results in elevated antibody production.
 - 
                                            
Pathways
 - Cellular Response to Molecule of Bacterial Origin, Regulation of Leukocyte Mediated Immunity, Production of Molecular Mediator of Immune Response, Maintenance of Protein Location, Cancer Immune Checkpoints
 
Target
 -